Commonwealth Equity Services, LLC Orasure Technologies Inc Transaction History

Commonwealth Equity Services, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$4.66 - $6.52 $49,186 - $68,818	10,555 New	10,555 $63,000
Q2 2022 Jul 19, 2022	SELL	$2.71 - $7.12 $4,878 - $12,816	-1,800 Reduced 11.26%	14,184 $38,000
Q1 2022 May 04, 2022	BUY	$6.62 - $9.33 $13,339 - $18,799	2,015 Added 14.42%	15,984 $108,000
Q4 2021 Jan 31, 2022	BUY	$8.3 - $11.29 $27,904 - $37,956	3,362 Added 31.7%	13,969 $121,000
Q3 2021 Oct 29, 2021	BUY	$9.73 - $13.38 $836 - $1,150	86 Added 0.82%	10,607 $119,000
Q2 2021 Aug 11, 2021	SELL	$9.02 - $11.68 $5,267 - $6,821	-584 Reduced 5.26%	10,521 $106,000
Q1 2021 May 04, 2021	BUY	$9.53 - $15.42 $371 - $601	39 Added 0.35%	11,105 $129,000
Q4 2020 Feb 11, 2021	BUY	$10.35 - $15.94 $114,533 - $176,392	11,066 New	11,066 $117,000

205

65.4M

2.2K

5.1K

Ticker OSUR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 72,619,104
Market Cap $285M
Description
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.